Veracyte Inc (VCYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,075 | -33,704 | -25,691 | -16,746 | -7,610 |
| Depreciation Amortization | 424 | 403 | 253 | 70 | -111 |
| Accounts receivable | 207 | -558 | -550 | -589 | 466 |
| Accounts payable and accrued liabilities | 301 | -3,546 | -1,831 | -4,637 | -356 |
| Other Working Capital | -715 | 550 | -3,022 | -6,462 | -2,410 |
| Other Operating Activity | 1,260 | 9,890 | 6,706 | 8,031 | 1,154 |
| Operating Cash Flow | $-8,598 | $-26,965 | $-24,135 | $-20,333 | $-8,867 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,855 | -6,165 | -1,975 | -852 | -511 |
| Other Investing Activity | -120 | -533 | -533 | -533 | 70 |
| Investing Cash Flow | $-2,975 | $-6,698 | $-2,508 | $-1,385 | $-441 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 24,600 | N/A | N/A | N/A | N/A |
| Debt Repayment | -5,288 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 633 | 37,980 | 37,942 | 37,749 | 92 |
| Other Financing Activity | 0 | -247 | -197 | 0 | 0 |
| Financing Cash Flow | $19,945 | $37,733 | $37,745 | $37,749 | $92 |
| Beginning Cash Position | 39,084 | 35,014 | 35,014 | 35,014 | 35,014 |
| End Cash Position | 47,456 | 39,084 | 46,116 | 51,045 | 25,798 |
| Net Cash Flow | $8,372 | $4,070 | $11,102 | $16,031 | $-9,216 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,598 | -26,965 | -24,135 | -20,333 | -8,867 |
| Capital Expenditure | -2,855 | -6,165 | -1,975 | -852 | -511 |
| Free Cash Flow | -11,453 | -33,130 | -26,110 | -21,185 | -9,378 |